Swathi Beladakere Ramaswamy Raghav Govindarajan
10.3233/JND-200520
J Neuromuscul Dis
2020;7(3):361-364.
covid-19 plasmapheresis refractory myasthenia gravis immunosuppression outcome
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/32508329/
Betacoronavirus Coronavirus Infections / complications Immunosuppressive Agents / therapeutic use Myasthenia Gravis / drug therapy Pneumonia, Viral / complications
Betacoronavirus Coronavirus Infections / complications Immunosuppressive Agents / therapeutic use Myasthenia Gravis / drug therapy Pneumonia, Viral / complications Case Reports Adult COVID-19 Chronic Disease Female Humans Myasthenia Gravis / complications Pandemics Precision Medicine / methods Risk Factors SARS-CoV-2 Treatment Outcome Immunosuppressive Agents
PMC7369032
32508329
COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome
2020